Furthermore, CVID patients with bronchiectasis have significantly lower IgA and IgM serum levels, lower total B cell and switched memory B cell numbers, expanded CD21lo immature B cells, as well as fewer T CD4+ cells than those without bronchiectasis [47,48]. This evidence concerns the gene CD40LG and bronchiectasis.